Cargando…
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
COVID-19 has threatened the existence of humanity andthis infection occurs due to SARS-CoV-2 or novel coronavirus, was first reported in Wuhan, China. Therefore, there is a need to find a promising drug to cure the people suffering from the infection. The second wave of this viral infection was shak...
Autores principales: | Raman, Anirudh Pratap Singh, Kumari, Kamlesh, Jain, Pallavi, Vishvakarma, Vijay Kumar, Kumar, Ajay, Kaushik, Neha, Choi, Eun Ha, Kaushik, Nagendra Kumar, Singh, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779518/ https://www.ncbi.nlm.nih.gov/pubmed/35057031 http://dx.doi.org/10.3390/pharmaceutics14010135 |
Ejemplares similares
-
An understanding of coronavirus and exploring the molecular dynamics simulations to find promising candidates against the Mpro of nCoV to combat the COVID-19: A systematic review
por: Singh, Madhur Babu, et al.
Publicado: (2022) -
A comparative study of 5- fluorouracil, doxorubicin, methotrexate, paclitaxel for their inhibition ability for Mpro of nCoV: Molecular docking and molecular dynamics simulations
por: Singh, Madhur Babu, et al.
Publicado: (2022) -
In silico study of remdesivir with and without ionic liquids having different cations using DFT calculations and molecular docking
por: Kumari, Kamlesh, et al.
Publicado: (2022) -
Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021) -
Xanthene based hybrid analogues to inhibit protease of novel corona Virus: Molecular docking and ADMET studies
por: Kumar Vishvakarma, Vijay, et al.
Publicado: (2020)